{"name":"Rosuvastatin","slug":"rosuvastatin","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Creston","X-Plended","Rosuvastatina","Zd-4522","Zd4522","rosuvastatinum","C10aa07","rosuvastatine","Rosuvastatin Acid","Creston (TN)"],"brands":["Crestor"],"scraped":true,"has_structure":true,"cid":446157,"classes":[],"families":[{"name":"carboxylic acid","href":"/substituted/carboxylic_acid"}],"physical":[{"label":"Molecular mass","value":"481.50 g/mol","copyable":false},{"label":"Solubility","value":"Sparingly soluble in water","copyable":false},{"label":"Predicted LogP","value":"1.6","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>22</sub>H<sub>28</sub>FN<sub>3</sub>O<sub>6</sub>S","copyable":true},{"label":"IUPAC name","value":"(E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid","copyable":true},{"label":"SMILES","value":"CC(C)C1=NC(=NC(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C","copyable":true},{"label":"InChI","value":"InChI=1S/C22H28FN3O6S/c1-13(2)20-18(10-9-16(27)11-17(28)12-19(29)30)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)33(4,31)32/h5-10,13,16-17,27-28H,11-12H2,1-4H3,(H,29,30)/b10-9+/t16-,17-/m1/s1","copyable":true},{"label":"InChIKey","value":"BPRHUIZQVSMCRT-VEUZHWNKSA-N","copyable":true},{"label":"CAS number","value":"287714-41-4","copyable":true},{"label":"UNII","value":"413KH5ZJ73","copyable":true},{"label":"PubChem CID","value":"446157","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"19 hours","copyable":false},{"label":"Metabolism","value":"Liver: CYP2C9 (major) and CYP2C19-mediated; ~10% metabolized","copyable":false},{"label":"Excretion","value":"Feces (90%)","copyable":false},{"label":"Routes of administration","value":"Oral (by mouth)","copyable":false}],"toxicity":[],"dosing":null,"salts":[{"title":"Sodium rosuvastatin","name":"sodium","slug":"sodium_rosuvastatin","drawn":true}],"esters":[],"chirality":"absolute","stereo_type":null,"optical_activity":"( + )","stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[{"code":"C","description":"Cardiovascular system"},{"code":"C10","description":"Lipid modifying agents"},{"code":"C10A","description":"Lipid modifying agents, plain"},{"code":"C10AA","description":"Hmg coa reductase inhibitors"},{"code":"C10AA07","description":""},{"code":"C10AA07","description":"Rosuvastatin"}],"mesh":[{"name":"Anticholesteremic Agents","id":"M0001378"},{"name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","id":"M0028567"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"ABCG2","mechanisms":["transporter inhibition","transporter induction"],"partners":29,"contraindicated":0},{"target":"SLCO1B1","mechanisms":["transporter inhibition","transporter induction"],"partners":22,"contraindicated":0}],"mechanism":"Rosuvastatin is a statin medication and a competitive inhibitor of the enzyme HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase, which catalyzes the conversion of HMG-CoA to mevalonate, an early rate-limiting step in cholesterol biosynthesis. Rosuvastatin acts primarily in the liver, where decreased hepatic cholesterol concentrations stimulate the upregulation of hepatic low density lipoprotein (LDL) receptors which increases hepatic uptake of LDL. Rosuvastatin also inhibits hepatic synthesis of very low density lipoprotein (VLDL). The overall effect is a decrease in plasma LDL and VLDL.   In vitro and in vivo animal studies also demonstrate that rosuvastatin exerts vasculoprotective effects independent of its lipid-lowering properties, also known as the pleiotropic effects of statins. This includes improvement in endothelial function, enhanced stability of atherosclerotic plaques, reduced oxidative stress and inflammation, and inhibition of the thrombogenic response.  Statins have also been found to bind allosterically to β2 integrin function-associated antigen-1 (LFA-1), which plays an important role in leukocyte trafficking and in T cell activation.  Rosuvastatin exerts an anti-inflammatory effect on rat mesenteric microvascular endothelium by attenuating leukocyte rolling, adherence and transmigration. The drug also modulates nitric oxide synthase (NOS) expression and reduces ischemic-reperfusion injuries in rat hearts. Rosuvastatin increases the bioavailability of nitric oxide by upregulating NOS and by increasing the stability of NOS through post-transcriptional polyadenylation. It is unclear as to how rosuvastatin brings about these effects though they may be due to decreased concentrations of mevalonic acid.","side_effects":{"drug_id":129806,"drug_name":"rosuvastatin","url":"https://sideeffects.embl.de/drugs/129806/pt","atc_codes":["C10AA07"],"side_effects":[{"name":"Headache","cui":"C0018681"},{"name":"Dizziness","cui":"C0012833"},{"name":"Arthralgia","cui":"C0003862"},{"name":"Musculoskeletal discomfort","cui":"C0948594"},{"name":"Myalgia","cui":"C0231528"},{"name":"Nausea","cui":"C0027497"},{"name":"Constipation","cui":"C0009806"},{"name":"Diabetes mellitus","cui":"C0011849"},{"name":"Asthenia","cui":"C0004093"},{"name":"Abdominal pain","cui":"C0000737"},{"name":"Gastrointestinal pain","cui":"C0687713"},{"name":"Dermatitis","cui":"C0011603"},{"name":"Rash","cui":"C0015230"},{"name":"Pruritus","cui":"C0033774"},{"name":"Urticaria","cui":"C0042109"},{"name":"Amnesia","cui":"C0002622"},{"name":"Memory loss","cui":"C0751295"},{"name":"Angioedema","cui":"C0002994"},{"name":"Arrhythmia","cui":"C0003811"},{"name":"Mental disorder","cui":"C0004936"},{"name":"Breast disorder","cui":"C0006145"},{"name":"Confusional state","cui":"C0009676"},{"name":"Feeling abnormal","cui":"C1443060"},{"name":"Depression","cui":"C0011570"},{"name":"Gynaecomastia","cui":"C0018418"},{"name":"Blood disorder","cui":"C0018939"},{"name":"Hepatitis","cui":"C0019158"},{"name":"Hypersensitivity","cui":"C0020517"},{"name":"Jaundice","cui":"C0022346"},{"name":"Renal failure acute","cui":"C0022660"},{"name":"Myopathy","cui":"C0026848"},{"name":"Musculoskeletal disorder","cui":"C0026857"},{"name":"Myoglobinuria","cui":"C0027080"},{"name":"Myoglobin urine present","cui":"C0853875"},{"name":"Myositis","cui":"C0027121"},{"name":"Nightmare","cui":"C0028084"},{"name":"Pancreatitis","cui":"C0030305"},{"name":"Neuropathy peripheral","cui":"C0031117"},{"name":"Rhabdomyolysis","cui":"C0035410"},{"name":"Thrombocytopenia","cui":"C0040034"},{"name":"Hepatic failure","cui":"C0085605"},{"name":"Muscular weakness","cui":"C0151786"},{"name":"Memory impairment","cui":"C0233794"},{"name":"Forgetfulness","cui":"C0542476"},{"name":"Hepatobiliary disease","cui":"C0267792"},{"name":"Muscle swelling","cui":"C0281913"},{"name":"Cognitive disorder","cui":"C0009241"},{"name":"Drug interaction","cui":"C0687133"},{"name":"Sleep disorder","cui":"C0851578"},{"name":"Insomnia","cui":"C0917801"},{"name":"Immune-mediated necrotising myopathy","cui":"C3267047"},{"name":"Nervous system disorder","cui":"C0027765"},{"name":"Bronchitis","cui":"C0006277"},{"name":"Infection","cui":"C0009450"},{"name":"Diarrhoea","cui":"C0011991"},{"name":"Dyspepsia","cui":"C0013395"},{"name":"Flatulence","cui":"C0016204"},{"name":"Gastroenteritis","cui":"C0017160"},{"name":"Haematuria","cui":"C0018965"},{"name":"Microscopic hematuria","cui":"C0239937"},{"name":"Influenza","cui":"C0021400"},{"name":"Nephropathy","cui":"C0022658"},{"name":"Hypertonia","cui":"C0026826"},{"name":"Pain","cui":"C0030193"},{"name":"Paraesthesia","cui":"C0030554"},{"name":"Pharyngitis","cui":"C0031350"},{"name":"Proteinuria","cui":"C0033687"},{"name":"Protein urine present","cui":"C0948586"},{"name":"Rhinitis","cui":"C0035455"},{"name":"Sinusitis","cui":"C0037199"},{"name":"Urinary tract infection","cui":"C0042029"},{"name":"Blood creatine phosphokinase increased","cui":"C0853034"},{"name":"Injury","cui":"C3263723"},{"name":"Hepatic enzyme increased","cui":"C0235996"},{"name":"Urine analysis abnormal","cui":"C0438142"},{"name":"Cough","cui":"C0010200"}],"indications":[{"name":"Alcoholism","cui":"C0001973"},{"name":"Atherosclerosis","cui":"C0004153"},{"name":"Cardiovascular disorder","cui":"C0007222"},{"name":"Cerebrovascular accident","cui":"C0038454"},{"name":"Coronary heart disease","cui":"C0010068"},{"name":"Diabetes mellitus","cui":"C0011849"},{"name":"Dyslipidaemia","cui":"C0242339"},{"name":"Heterozygous familial hypercholesterolemia","cui":"C0342882"},{"name":"Homozygous familial hypercholesterolaemia","cui":"C0342881"},{"name":"Hypercholesterolaemia","cui":"C0020443"},{"name":"Hyperlipidaemia","cui":"C0020473"},{"name":"Hypertriglyceridaemia","cui":"C0020557"},{"name":"Hypothyroidism","cui":"C0020676"},{"name":"Liver disorder","cui":"C0023895"},{"name":"Myocardial infarction","cui":"C0027051"},{"name":"Nephrotic syndrome","cui":"C0027726"},{"name":"Type II hyperlipidaemia","cui":"C0020445"},{"name":"Type III hyperlipidaemia","cui":"C0020479"}]},"effects":null,"usernotes":[{"user":"0xea","user_slug":"0xea","external":false,"note":{"substance":"Rosuvastatin","composite":false,"routes":[{"name":"Oral","dosage":"10-20mg","onset":null,"comeup":null,"duration":null,"active":null}],"dosages":[],"classes":[],"forms":["Calcium"],"sources":[],"indications":["genetically elevated {sub 'cholesterol'} levels"],"effects":[],"conditional_effects":[],"after_effects":[],"tolerance":[],"odor":[],"notes":[]}}],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Australia","status":"Schedule 4","act":null,"refs":[]},{"jurisdiction":"Canada","status":"Prescription only","act":null,"refs":[3]},{"jurisdiction":"United Kingdom","status":"Prescription only","act":null,"refs":[4]},{"jurisdiction":"United States","status":"Prescription only","act":null,"refs":[]},{"jurisdiction":"Other","status":"Rx-only","act":null,"refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Rosuvastatin"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/446157"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q415159"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB01098"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1496"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A38545"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=287714-41-4"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0015230"},{"source":"KEGG","url":"https://www.kegg.jp/entry/D08492"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID8048492"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Rosuvastatin"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/413KH5ZJ73"},{"source":"SIDER","url":"https://sideeffects.embl.de/drugs/129806/pt"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 446157, Rosuvastatin. Accessed November 20, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/446157>https://pubchem.ncbi.nlm.nih.gov/compound/446157</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Rosuvastatin. UNII: 413KH5ZJ73. Global Substance Registration System. Accessed November 20, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/413KH5ZJ73>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/413KH5ZJ73</a>","Crestor Product information. Health Canada. 25 April 2012. <a href='https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&amp;code=71404'>https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&amp;code=71404</a>","Crestor 10mg film-coated tablets - Summary of Product Characteristics (SmPC). (emc). 29 September 2020. <a href='https://www.medicines.org.uk/emc/product/7559/smpc'>https://www.medicines.org.uk/emc/product/7559/smpc</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 16:00:43","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 16:00:39","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 16:00:39","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 16:00:40","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 16:00:39","note":"hmdb.ca refused automated access to HMDB0015230"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 16:00:42","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 16:00:38","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 16:00:39","note":"no r/tripreports posts mention it"},{"source":"sider","status":"ok","fetched_at":"2026-11-20 16:00:39","note":null},{"source":"structure","status":"ok","fetched_at":"2026-11-20 16:00:39","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 16:00:39","note":null}],"description":"Rosuvastatin is a  substance."}